Emerging Hsp90 Inhibitors: From Discovery to Clinic

E-ISSN： 1875-5992|6|1|1-8

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.6, Iss.1, 2006-01, pp. : 1-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in Hsp90 Inhibitors as Antitumor Agents

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 7, 2008-10 ,pp. : 761-782

Bentham Science Publishers

Access to resources Recommend Favorite

HSP90 Inhibitors: Current Development and Potential in Cancer Therapy

Recent Patents on Anti-Cancer Drug Discovery, Vol. 9, Iss. 1, 2014-01 ,pp. : 1-20

Bentham Science Publishers

Access to resources Recommend Favorite

Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells

International Journal of Oncology, Vol. 43, Iss. 6, 2013-01 ,pp. : 1824-1832

Spandidos Publications

Access to resources Recommend Favorite

HSP90: Chaperone-me-not

By Patki J. Pawar S.

Pathology & Oncology Research, Vol. 19, Iss. 4, 2013-10 ,pp. : 631-640

Springer Publishing Company

Access to resources Recommend Favorite

Improving the Hsp90 Inhibitors Containing 4-(2,4-Dihydroxyphenyl)-1,2,3-thiadiazole Scaffold: Synthesis, Affinity and Effect on Cancer Cells

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 11, 2017-11 ,pp. : 1593-1603

Bentham Science Publishers

Access to resources Recommend Favorite